CN
|
EN
Home
Introduction to the 2022 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Register
Roadshow Application
Roadshow Center)
CN
EN
R&D Service Company Roadshow (CRO, CMO, CDMO)
Schedule
Profile details
13:30 PM-17:40 PM
Moderator
常建青,泰格医药政策法规事务副总裁
CHANG Jianqing,Vice President of Regulatory Policy, Hangzhou Tigermed Consulting Co., Ltd.
13:30 PM-14:00 PM
主题报告1
Keynote Speech
以临床价值为导向的审评审批新进展及其CRO的机遇与挑战
Latest progress of the Clinical Value Oriented IND and NDA Review , Opportunities and Challenges to CRO
常建青,泰格医药政策法规事务副总裁
CHANG Jianqing,Vice President of Regulatory Policy, Hangzhou Tigermed Consulting Co., Ltd.
14:00 PM-14:20 PM
项目1
Project 1
MiniPDX® 赋能精准医疗和新药研发
MiniPDX® for Precision Medicine and New Drug R&D
闻丹忆,上海立迪生物技术股份有限公司董事长兼CEO
WEN Danyi, President & CEO, Shanghai LIDE Biotech. Co., Ltd.
14:20 PM-14:40 PM
项目2
Project 2
助力中国国际化创新
Advance China's Internationalization Innovation
闫慧, 缔脉生物医药科技(上海)有限公司中国区总裁
Angela YAN, CChina President, dMed Biopharmaceutical Co., Ltd.
14:40 PM-15:10 PM
项目3
Project 3
真实世界研究中的生物统计师
Biostatiscian in Real World Study
赵建民, 国信医药科技(北京)有限公司副总裁兼首席统计官
ZHAO Jianmin,VP, GX Pharma Technology(Beijing)Co., Ltd.
15:10 PM-15:30 PM
项目4
Project 4
CRO如何助力药企的国际化发展策略
How CRO Assist Strategical Globalization and Development of Pharmaceutical Companies
戴学东, 上海美迪西生物医药股份有限公司国际研发服务部执行副总裁
DAI Xuedong,Executive Vice President Head of International Discovery Service Unit of Shanghai Medicilon inc.
15:30 PM-15:50 PM
项目5
Project 5
临床CRO的技术创新赋能药物研发
Innovation of Clinical CRO Empowering Drug Development
姜海, 润东医药研发(上海)有限公司总裁/CEO
JIANG Hai,CEO of Rundo International Pharmaceutical Research & Development Co., Ltd.
15:50 PM-16:10 PM
项目6
Project 6
为创新药出海赋能,国际多中心临床的全球战略合作伙伴
Next Generation Global Clinical CRO- Strategic Partner with Emerging Biotech Companies
付萌, 锐得麦医药创始人兼首席执行官
Amanda FU, Founder & CEO, Redbud Medicine Co., Ltd.
16:10 PM-16:40 PM
主题报告2
Keynote Speech
创新药大环境下CDMO企业的机遇和挑战
Opportunities and Challenges of CDMO Enterprises under the Environment of Innovative Drugs
李原强, 浙江九洲药业股份有限公司首席科学官
LI Yuanqiang,CSO, Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
16:40 PM-17:00 PM
项目7
Project 7
伴随诊断助力肿瘤新药研发
Companion Diagnostics Facilitate Development of Innovative Oncology Therapeutics
董正伟, 厦门艾德生物医药科技股份有限公司业务拓展部高级总监
Harvey DONG, Senior Director of Business Development, Amoy Diagnostics Co., Ltd.
17:00 PM-17:20 PM
项目8
Project 8
端到端的 CDMO服务助力基因细胞治疗药物研发
End-to-end CDMO Services Help Gene Cell Therapy Drug Discovery
孔令洁, 苏州博腾生物制药有限公司首席技术官
KONG Lingjie, CTO, Porton Biologics Ltd.
17:20 PM-17:40 PM
项目9
Project 9
北大生物——为您打入欧美日市场的生物大使
Peking University Biologics——"Biologics Ambassador" to China, Japan, USA, and Europe
陈晋宇, 北大未名(合肥)生物制药有限公司首席执行官
Wayne TAN, CEO, Peking University V-Ming (Hefei) BIologics Co., Ltd.
Specification:
Released:
September 17, 2020
Last update:
September 19, 2020
Version:
1.1
010-58156160
Contact US